REG - Cadence Minerals PLC - Exercise of Warrants

Cadence MineralsAnnouncement

14/08/2020 13:05

RNS Number : 2183W
  
Cadence Minerals PLC
  
14 August 2020
  
 

Cadence Minerals Plc
("Cadence Minerals", "Cadence" or "the Company")
 
Exercise of Warrants
 
Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) is pleased to announce that it has received warrant exercise notices to subscribe for a total of 537,500 new ordinary shares in the Company at an exercise price of 6 pence per share (the "New Ordinary Shares"). Subscription monies of £32,250 have been received by the Company in respect of the exercise of these warrants.
 
Application will be made for the admission to trading on the AIM market ("AIM") of London Stock Exchange plc ("LSE") and to and the AQSE Growth Market ("AQSE") operated by Aquis Exchange Plc for the New Ordinary Shares ("Admission").
 
Admission is expected to occur on or around 20 August 2020. Following Admission, the Company will have  129,802,391 Ordinary Shares in issue. There are no shares held in treasury. The total voting rights in the Company is therefore   129,802,391 and Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.
 
 



For further information:
 



Cadence Minerals plc


                                                   +44 (0) 7879 584153




Andrew Suckling


 




Kiran Morzaria


 




 


 




WH Ireland Limited (NOMAD & Broker)


                                +44 (0) 207 220 1666




James Joyce


 




James Sinclair-Ford


 




 


 




Novum Securities Limited (Joint Broker)


                                +44 (0) 207 399 9400




Jon Belliss


 



 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
IOEUSRURRAUWAAR